Efficacy and safety of pegylated recombinant human granulocyte colony-stimulating factor secondary prophylaxis in capecitabine combined with oxaliplatin (CapeOX) regimen in the treatment of colorectal cancer
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
Interventions: Experimental group:The test drug PEG-rhG-CSF injection was administered 24-48 hours after the end of oxaliplatin intravenous infusion Primary outcome(s): The incidence of 2-4 grade neutropenia during the treatment period Study Design: Single arm
创建时间：
2021-11-15
